FDG-PET in the detection of residual disease and relapse in patients with Hodgkin's lymphoma. Experience from a Swedish centre

被引：10
作者：
Bjurberg, Maria [1 ]
Gustavsson, Anita
Ohlsson, Tomas
Brun, Eva
机构：
[1] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden
[2] Univ Lund Hosp, Dept Radiat Phys, S-22185 Lund, Sweden
来源：
ACTA ONCOLOGICA | 2006年 / 45卷 / 06期
关键词：
D O I：
10.1080/02841860600644724
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The aim of this retrospective study was to compare the value of FDG-PET with conventional imaging in patients with residual disease or suspected relapse in Hodgkin's lymphoma (HL). We reviewed the records of all patients with HL who were referred for FDG-PET at our PET centre between April 2002 and August 2004. Thirty-four FDG-PET scans performed on 26 patients were included in the study. Referrals were based on either the presence of a residual mass on computed tomography (CT) (n = 13) or suspicion of relapse (n = 21). We found one false negative and one false positive FDG- PET scan. The high positive predictive value of FDG- PET in the residual group and the high negative predictive value in the relapse group strongly indicate that FDG- PET has an important role to play in the management of HL.
引用
收藏
页码：743 / 749
页数：7
相关论文
共 27 条
[1]  
de Hemricourt Erard, 2003, Mol Imaging Biol, V5, P15, DOI 10.1016/S1536-1632(02)00123-3
[2]   18FDG-PET following treatment as valid predictor for disease-free survival in Hodgkin's lymphoma [J].
de Wit, M ;
Bohuslavizki, KH ;
Buchert, R ;
Bumann, D ;
Clausen, M ;
Hossfeld, DK .
ANNALS OF ONCOLOGY, 2001, 12 (01) :29-37
[3]   Part II: Hodgkin's lymphoma - diagnosis and treatment [J].
Diehl, V ;
Thomas, RK ;
Re, D .
LANCET ONCOLOGY, 2004, 5 (01) :19-26
[4]  
Dittmann H, 2001, ONCOL REP, V8, P1393
[5]  
Döbert N, 2004, Q J NUCL MED MOL IM, V48, P33
[6]  
FACEY K, 2004, ULTRA RAPID REV POSI
[7]  
Guay C, 2003, J NUCL MED, V44, P1225
[8]  
Hueltenschmidt B, 2001, CANCER-AM CANCER SOC, V91, P302, DOI 10.1002/1097-0142(20010115)91:2<302::AID-CNCR1002>3.0.CO
[9]  
2-4
[10]   FDG-PET in the clinical management of Hodgkin lymphoma [J].
Hutchings, M ;
Eigtved, AI ;
Specht, L .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 52 (01) :19-32
123